Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nike | INDUSTRY |
The following study proposes to investigate the injury risk associated with the use of a new category of running footwear: the minimalist shoe. A group of experienced adult male and female runners with neutral foot types will take part in this study. All participants will be randomized to receive one of three different shoes: a full minimalist shoe (Vibram 5-Fingers), a partial minimalist shoe (Nike Free 3.0) and a conventional neutral supportive running shoe (Nike Pegasus), while training for a 10k event over a 14-week period. Outcomes to be investigated are pain, footwear perception, and number of injury events.
The hypothesizes is that participants using the minimalist footwear during their running program will experience a reduction in running related pain. A greater degree of footwear minimalism will result in a greater reduction in pain (compared to the partial minimalist shoe, Nike Free).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neutral Shoe | Active Comparator | Conventional, non-minimalist, footwear. |
|
| Partial minimalist shoe | Experimental |
| |
| Full minimalist | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nike Pegasus | Other | Conventional neutral supportive running footwear. Non minimalist. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Injury Events | Number of run injury events (defined as unable to complete 3 consecutive running workouts due to running related pain). A calculation of injury incidence will be based on this number after dividing by the number of athletic exposures. | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Foot and Ankle Disability Index (FADI) | Week 12 | |
| Numerical Pain Scale (NPS) for Overall Running Related Pain | Week 12 | |
| Regional Specific NPS: Shin and Calf Pain |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jack Taunton, MD | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of British Columbia | Vancouver | British Columbia | V6T 1Z3 | Canada |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Nike Free 3.0 |
| Other |
Partial minimalist shoe with partially elevated heel, but with increased mid-sole flexibility. |
|
| Vibram Five Fingers Shoe | Other | Full minimalist shoe. Virtually no mid-sole, therefore no heel elevation or forefoot rockering. A proxy for a barefoot running condition. |
|
| Week 12 |
| Regional Specific NPS: Foot and Ankle Pain | 12 Week |
| Regional Specific NPS: Knee Pain | 12 Weeks |
| Regional Specific NPS: Pelvis and Groin Pain | 12 Week |
| Regional Specific NPS: Lower Back Pain | 12 Week |